You are here:

Home
NICE Guidance
Conditions and diseases
Mental health, behavioural and neurodevelopmental conditions
Dementia

Dementia Products

A list of all our products on dementia

Filter

Product type

Product typeGuidanceQuality standards

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceInterventional procedures guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic prioritisation

New and updated

New and updatedNew in the last 6 months

Showing 2 products

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer’s disease [ID4043]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
28 April 2026
Expected publication date:
TBC
Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
28 April 2026
Expected publication date:
TBC